FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Arja Rautio

Research Profile

Chemicals & Drugs

Anatomy

Co-author Network

Publications

TOP 3
Pentti Nieminen; Antti Huusko; Heli Lehtiniemi; Kirsi Vähäkangas; Arja Rautio
Polychlorinated biphenyls (PCBs) in relation to secondary sex ratio--a systematic review of published studies.
Tiina Lankila; Simo Näyhä; Arja Rautio; Jarmo Rusanen; Markku Koiranen; Anja Taanila
Health and well-being of movers in rural and urban areas--a grid-based analysis of northern Finland birth cohort 1966.
Tiina Lankila; Simo Näyhä; Tanja Nordström; Arja Rautio; Markku Koiranen; Anja Taanila; Jarmo Rusanen
Self-reported health in urban-rural continuum: a grid-based analysis of Northern Finland Birth Cohort 1966.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Arja Rautio (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Pentti Nieminen; Antti Huusko; Heli Lehtiniemi; Kirsi Vähäkangas; Arja Rautio
Polychlorinated biphenyls (PCBs) in relation to secondary sex ratio--a systematic review of published studies.
Chemosphere 2013;91(2):131-8.
2013: Tiina Lankila; Simo Näyhä; Arja Rautio; Jarmo Rusanen; Markku Koiranen; Anja Taanila
Health and well-being of movers in rural and urban areas--a grid-based analysis of northern Finland birth cohort 1966.
Social science & medicine (1982) 2013;76(1):169-78.
2012: Tiina Lankila; Simo Näyhä; Tanja Nordström; Arja Rautio; Markku Koiranen; Anja Taanila; Jarmo Rusanen
Self-reported health in urban-rural continuum: a grid-based analysis of Northern Finland Birth Cohort 1966.
International journal of public health 2012;57(3):525-33.
2012: Mari Murtomaa-Hautala; Olavi Pelkonen; Raimo Pohjanvirta; Arja Rautio; Pirkko Viitala; Nagabhooshan Hegde; Heikki Henttonen; Otso Huitu; Merja Korkalainen; Matti Viluksela
Significant interspecies differences in induction profiles of hepatic CYP enzymes by TCDD in bank and field voles.
Environmental toxicology and chemistry / SETAC 2012;31(3):663-71.
2011: Kati Oravisjärvi; Mari Pietikäinen; Arja Rautio; Juhani Ruuskanen; Arto Voutilainen; RL Keiski
Effects of physical activity on the deposition of traffic-related particles into the human lungs in silico.
The Science of the total environment 2011;409(21):4511-8.
2010: Mari Murtomaa; Olavi Pelkonen; Juho Hokkanen; Pirkko Viitala; Arja Rautio
Xenobiotic metabolism of bank vole (Myodes glareolus) exposed to PCDDs.
Environmental toxicology and pharmacology 2010;29(1):19-23.
2009: Mari Pietikäinen; Kati Oravisjärvi; Arja Rautio; Arto Voutilainen; Juhani Ruuskanen; RL Keiski
Exposure assessment of particulates of diesel and natural gas fuelled buses in silico.
The Science of the total environment 2009;408(1):163-8.
2005: Olavi Pelkonen; Miia Turpeinen; Jouko Uusitalo; Arja Rautio; Hannu Raunio
Prediction of drug metabolism and interactions on the basis of in vitro investigations.
Basic & clinical pharmacology & toxicology 2005;96(3):167-75.
2005: Arja Rautio; Vappu Sunnari; Matti Nuutinen; Marja Laitala
Mistreatment of university students most common during medical studies.
BMC medical education 2005;5():36.
2005: Markku Anttila; Eero A Sotaniemi; Olavi Pelkonen; Arja Rautio
Marked effect of liver and kidney function on the pharmacokinetics of selegiline.
Clinical pharmacology and therapeutics 2005;77(1):54-62.
2003: Arja Rautio
Polymorphic CYP2A6 and its clinical and toxicological significance.
The pharmacogenomics journal 2003;3(1):5-7.
2002: Mikael Oscarson; Roman A McLellan; Vendela Asp; MariCarmen Ledesma; Maria Luisa Bernal Ruiz; Blanca Sinues; Arja Rautio; Magnus Ingelman-Sundberg
Characterization of a novel CYP2A7/CYP2A6 hybrid allele (CYP2A6*12) that causes reduced CYP2A6 activity.
Human mutation 2002;20(4):275-83.
2002: Eero A Sotaniemi; Olavi Pelkonen; Arno J Arranto; Päivi Tapanainen; Arja Rautio; Markku Pasanen
Diabetes and elimination of antipyrine in man: an analysis of 298 patients classified by type of diabetes, age, sex, duration of disease and liver involvement.
Pharmacology & toxicology 2002;90(3):155-60.
2001: Hannu Raunio; Arja Rautio; H Gullstén; Olavi Pelkonen
Polymorphisms of CYP2A6 and its practical consequences.
British journal of clinical pharmacology 2001;52(4):357-63.
2000: Olavi Pelkonen; Arja Rautio; Hannu Raunio; Markku Pasanen
CYP2A6: a human coumarin 7-hydroxylase.
Toxicology 2000;144(1-3):139-47.
1999: Mikael Oscarson; Roman A McLellan; H Gullstén; José Agúndez; Julio Benitez; Arja Rautio; Hannu Raunio; Olavi Pelkonen; Magnus Ingelman-Sundberg
Identification and characterisation of novel polymorphisms in the CYP2A locus: implications for nicotine metabolism.
FEBS letters 1999;460(2):321-7.
1999: Hannu Raunio; Arja Rautio; Olavi Pelkonen
The CYP2A subfamily: function, expression and genetic polymorphism.
IARC scientific publications 1999;(148):197-207.
1999: Olavi Pelkonen; Hannu Raunio; Arja Rautio; M Lang
Xenobiotic-metabolizing enzymes and cancer risk: correspondence between genotype and phenotype.
IARC scientific publications 1999;(148):77-88.
1998: Olavi Pelkonen; Jukka Mäenpää; Päivi Taavitsainen; Arja Rautio; Hannu Raunio
Inhibition and induction of human cytochrome P450 (CYP) enzymes.
Xenobiotica; the fate of foreign compounds in biological systems 1998;28(12):1203-53.
1998: Mikael Oscarson; H Gullstén; Arja Rautio; M L Bernal; Blanca Sinues; Marja-Liisa Dahl; J H Stengård; Olavi Pelkonen; Hannu Raunio; Magnus Ingelman-Sundberg
Genotyping of human cytochrome P450 2A6 (CYP2A6), a nicotine C-oxidase.
FEBS letters 1998;438(3):201-5.
1997: Markku Pasanen; Z Rannala; A Tooming; Eero A Sotaniemi; Olavi Pelkonen; Arja Rautio
Hepatitis A impairs the function of human hepatic CYP2A6 in vivo.
Toxicology 1997;123(3):177-84.
1997: H Gullstén; José Agúndez; Julio Benitez; Esa Läärä; José M Ladero; M Díaz-Rubio; Pedro Fernandez-Salguero; F Gonzalez; Arja Rautio; Olavi Pelkonen; Hannu Raunio
CYP2A6 gene polymorphism and risk of liver cancer and cirrhosis.
Pharmacogenetics 1997;7(3):247-50.
1996: E A Sotaniemi; P Lumme; P Arvela; Arja Rautio
Age and CYP3A4 and CYP2A6 activities marked by the metabolism of lignocaine and coumarin in man.
Thérapie 1996;51(4):363-6.
1996: AL Rauma; Arja Rautio; Markku Pasanen; Olavi Pelkonen; R Törrönen; Hannu M Mykkänen
Coumarin 7-hydroxylation in long-term adherents of a strict uncooked vegan diet.
European journal of clinical pharmacology 1996;50(1-2):133-7.
1995: E A Sotaniemi; E Haapakoski; Arja Rautio
Ginseng therapy in non-insulin-dependent diabetic patients.
Diabetes care 1995;18(10):1373-5.
1995: Pedro Fernandez-Salguero; S M Hoffman; S Cholerton; Harvey W Mohrenweiser; H Raunio; Arja Rautio; Olavi Pelkonen; J D Huang; William Evans; Jeffrey Idle
A genetic polymorphism in coumarin 7-hydroxylation: sequence of the human CYP2A genes and identification of variant CYP2A6 alleles.
American journal of human genetics 1995;57(3):651-60.
1995: Jouko I T Isojärvi; K E Juhani Airaksinen; J N Mustonen; A J Pakarinen; Arja Rautio; Olavi Pelkonen; Vilho V Myllylä
Thyroid and myocardial function after replacement of carbamazepine by oxcarbazepine.
Epilepsia 1995;36(8):810-6.
1995: E A Sotaniemi; Arja Rautio; M Bäckstrom; P Arvela; Olavi Pelkonen
CYP3A4 and CYP2A6 activities marked by the metabolism of lignocaine and coumarin in patients with liver and kidney diseases and epileptic patients.
British journal of clinical pharmacology 1995;39(1):71-6.
1995: Jouko I T Isojärvi; A J Pakarinen; Arja Rautio; Olavi Pelkonen; Vilho V Myllylä
Serum sex hormone levels after replacing carbamazepine with oxcarbazepine.
European journal of clinical pharmacology 1995;47(5):461-4.
1995: Imre Klebovich; Arja Rautio; P Salonpää; P Arvela; Olavi Pelkonen; E A Sotaniemi
Antipyrine, coumarin and glipizide affect n-acetylation measured by caffeine test.
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 1995;49(5):225-7.
1994: Jouko I T Isojärvi; A J Pakarinen; Arja Rautio; Olavi Pelkonen; Vilho V Myllylä
Liver enzyme induction and serum lipid levels after replacement of carbamazepine with oxcarbazepine.
Epilepsia 1994;35(6):1217-20.
1994: J Mäenpää; Risto O Juvonen; Hannu Raunio; Arja Rautio; Olavi Pelkonen
Metabolic interactions of methoxsalen and coumarin in humans and mice.
Biochemical pharmacology 1994;48(7):1363-9.
1994: Pertti Mustajoki; Sami Mustajoki; Arja Rautio; P Arvela; Olavi Pelkonen
Effects of heme arginate on cytochrome P450-mediated metabolism of drugs in patients with variegate porphyria and in healthy men.
Clinical pharmacology and therapeutics 1994;56(1):9-13.
1994: Olavi Pelkonen; Arja Rautio; Hannu Raunio; J Mäenpää; Jukka Hakkola
Regulation of coumarin 7-hydroxylation in man.
Journal of cancer research and clinical oncology 1994;120 Suppl():S30-1.
1993: P Pellinen; Frej Stenbäck; Arja Rautio; Olavi Pelkonen; M Lang; Markku Pasanen
Response of mouse liver coumarin 7-hydroxylase activity to hepatotoxins: dependence on strain and agent and comparison to other monooxygenases.
Naunyn-Schmiedeberg's archives of pharmacology 1993;348(4):435-43.
1992: Arja Rautio; H Kraul; A Kojo; E Salmela; Olavi Pelkonen
Interindividual variability of coumarin 7-hydroxylation in healthy volunteers.
Pharmacogenetics 1992;2(5):227-33.
1992: E A Sotaniemi; Frej Stenbäck; Leila Risteli; J A Vuori; Arja Rautio; Risto Huupponen; Juha Risteli
Effect of insulin on serum amino-terminal propeptide of type III procollagen in non-insulin-dependent diabetes mellitus.
Diabetes research and clinical practice 1992;17(3):209-15.
1991: Jari H Stengård; H U Saarni; Arja Rautio; Mikael Knip; Frej Stenbäck; E A Sotaniemi
Effects of medroxyprogesterone acetate on liver glucose metabolism in rats with streptozotocin induced diabetes mellitus.
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et métabolisme 1991;23(11):567-9.
1991: Jari H Stengård; Frej Stenbäck; H U Saarni; Arja Rautio; E A Sotaniemi
Time dependent effects of medroxyprogesterone acetate on hepatic ultrastructure in rats.
Research communications in chemical pathology and pharmacology 1991;74(1):25-37.
1990: Hannu Raunio; J Valtonen; Paavo Honkakoski; M A Lang; M Ståhlberg; M A Kairaluoma; Arja Rautio; Markku Pasanen; Olavi Pelkonen
Immunochemical detection of human liver cytochrome P450 forms related to phenobarbital-inducible forms in the mouse.
Biochemical pharmacology 1990;40(11):2503-9.
1990: P V Luoma; Jari H Stengård; H Korpela; Arja Rautio; E A Sotaniemi; E Suvanto; Jukka Marniemi
Lipid peroxides, glutathione peroxidase, high density lipoprotein subfractions and apolipoproteins in young adults.
Journal of internal medicine 1990;227(4):287-9.
1990: P V Luoma; Arja Rautio; Jari H Stengård; E A Sotaniemi; Jukka Marniemi
High-density lipoprotein subfractions, apolipoproteins and antipyrine clearance in normal subjects.
European journal of clinical pharmacology 1990;38(6):625-7.
1989: Frej Stenbäck; H U Saarni; Arja Rautio; Jari H Stengård; E A Sotaniemi
Reversibility of rat liver cirrhosis by medroxyprogesterone acetate.
Toxicologic pathology 1989;17(1 Pt 1):38-45.
1987: Tapani Rönnemaa; H Järveläinen; A Lehtonen; M Grönroos; Jukka Marniemi; Arja Rautio
Growth of human aortic smooth muscle cells cultured with human serum is retarded when serum lipids are lowered by medroxyprogesterone.
Atherosclerosis 1987;67(2-3):223-8.
1986: H Raunio; Arja Rautio; A J Arranto; H U Saarni
Polyamine biosynthesis and monooxygenase enzyme activity in rat liver cirrhosis and regeneration.
Research communications in chemical pathology and pharmacology 1986;53(2):159-65.
1985: Arja Rautio; H U Saarni; A J Arranto; Jari H Stengård; N T Kärki; E A Sotaniemi
Metabolism of medroxyprogesterone acetate and hepatic drug metabolism activity.
Research communications in chemical pathology and pharmacology 1985;47(2):305-8.
1985: A Lehtonen; M Grönroos; Jukka Marniemi; P Peltonen; M Mäntylä; J Niskanen; Arja Rautio; E Hietanen
Effects of high dose progestin on serum lipids and lipid metabolizing enzymes in patients with endometrial cancer.
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et métabolisme 1985;17(1):32-4.
1985: H U Saarni; A J Arranto; Arja Rautio; E A Sotaniemi
Treatment of liver cirrhosis with microsomal enzyme-inducing compound in the rat.
Journal of hepatology 1985;1(5):501-11.
1983: H U Saarni; Arja Rautio; N T Kärki; E A Sotaniemi
Disposition of medroxyprogesterone acetate and drug metabolism activity.
Research communications in chemical pathology and pharmacology 1983;39(2):251-60.
1982: A J Arranto; Arja Rautio; E A Sotaniemi
Pericellular collagen in alcoholics with liver cirrhosis.
Research communications in chemical pathology and pharmacology 1982;35(1):121-35.
1981: E A Sotaniemi; M Anttila; Arja Rautio; Jari H Stengård; P Saukko; P Järvensivu
Propranolol and sotalol metabolism after a drinking party.
Clinical pharmacology and therapeutics 1981;29(6):705-10.
1980: Arja Rautio; E A Sotaniemi; R O Pelkonen; P V Luoma
Treatment of alcoholic cirrhosis with enzyme inducers.
Clinical pharmacology and therapeutics 1980;28(5):629-37.